» Articles » PMID: 16824250

Prevalence of Hepatitis C in a German Prison for Young Men in Relation to Country of Birth

Overview
Date 2006 Jul 11
PMID 16824250
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

A high prevalence of hepatitis C (HCV) virus infection of up to 80% has been reported for injecting drug users (IDUs) in prison communities. However, there are only very limited data available on the prevalence and course of HCV in young offenders. We performed a study on hepatitis C markers in the largest German Young Offenders' Institution (YOI), a prison for men (aged 16-24 years). In 2002, all 1176 incoming offenders were asked to participate in the study of whom >95% agreed. Ninety-seven inmates (8.6%) tested positive for anti-HCV or HCV RNA, 79% of whom were viraemic. None of the patients had evidence of cirrhosis at presentation. Interestingly, six individuals (6%) tested positive for HCV RNA in the absence of anti-HCV antibodies, four of whom cleared HCV spontaneously during follow-up without either clinical signs of acute hepatitis or developing HCV antibodies. Hepatitis C markers were significantly more prevalent among immigrants from the former Soviet Union (NIS) than among German inmates (31% vs. 6% respectively, P<0.0001). HIV co-infection was found in five individuals, all of whom were German. In contrast, hepatitis B surface antigen (HBsAg) was detected in five NIS immigrants, one Lebanese and one German inmate. HCV genotypes 2 and 3 were more prevalent in immigrants than in German inmates, while biochemical parameters did not differ significantly between the two groups. In conclusion, the prevalence of hepatitis C was relatively low among inmates of German YOIs although there were significant differences in relation to the country of birth. Our data highlight the need for educational programmes for young offenders in order to prevent the further spread of HCV.

Citing Articles

[Strategietreffen: Virushepatitis in Deutschland eliminieren].

Tergast T, Protzer U, Zeuzem S, Heitmann L, Sarrazin C, Lehmann M Z Gastroenterol. 2023; 61(2):198-201.

PMID: 36736343 PMC: 9897951. DOI: 10.1055/a-1978-9021.


Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prison.

Okafor I, Ugwu S, Okoroiwu H BMC Gastroenterol. 2020; 20(1):360.

PMID: 33126856 PMC: 7602341. DOI: 10.1186/s12876-020-01504-8.


Microelimination of Chronic Hepatitis C by Universal Screening Plus Direct-Acting Antivirals for Incarcerated Persons in Taiwan.

Yang T, Fang Y, Hsu S, Lee J, Chiu M, Yu J Open Forum Infect Dis. 2020; 7(8):ofaa301.

PMID: 32818142 PMC: 7423289. DOI: 10.1093/ofid/ofaa301.


Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe.

Stover H, Meroueh F, Marco A, Keppler K, Saiz de la Hoya P, Littlewood R BMC Public Health. 2019; 19(1):30.

PMID: 30621658 PMC: 6323720. DOI: 10.1186/s12889-018-6357-x.


Hepatitis C seropositivity among newly incarcerated prisoners in Estonia: data analysis of electronic health records from 2014 to 2015.

Kivimets K, Uuskula A, Lazarus J, Ott K BMC Infect Dis. 2018; 18(1):339.

PMID: 30031373 PMC: 6054745. DOI: 10.1186/s12879-018-3242-2.


References
1.
Wiese M, Berr F, Lafrenz M, Porst H, Oesen U . Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study. Hepatology. 2000; 32(1):91-6. DOI: 10.1053/jhep.2000.8169. View

2.
Weild A, Gill O, Bennett D, Livingstone S, Parry J, Curran L . Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health. 2000; 3(2):121-6. View

3.
Christensen P, Krarup H, Niesters H, Norder H, Georgsen J . Prevalence and incidence of bloodborne viral infections among Danish prisoners. Eur J Epidemiol. 2001; 16(11):1043-9. DOI: 10.1023/a:1010833917242. View

4.
Pessione F, Ramond M, Njapoum C, Duchatelle V, Degott C, Erlinger S . Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology. 2001; 34(1):121-5. DOI: 10.1053/jhep.2001.25385. View

5.
Long J, Allwright S, Barry J, Reynolds S, Thornton L, Bradley F . Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey. BMJ. 2001; 323(7323):1209-13. PMC: 59992. DOI: 10.1136/bmj.323.7323.1209. View